Professor Dr. Veysel Sabri Hançer graduated from Karşıyaka High School (Izmir, Turkey) in 1995 and Ege University Faculty of Science in 1999. After completing his Master's Degree at Ege University in 2001, he completed his PhD in 2009 at Istanbul University Molecular Biology and Genetics program. He studied at Molecular Hematology laboratory in Istanbul University between 2001 and 2010. Dr.Hancer received his Associate Professor and Professor degrees in 2013 and 2018 respectively. He is currently the head of the Department of Medical Biology, Faculty of Medicine, Istinye University. He is the ...
Professor Dr. Veysel Sabri Hançer graduated from Karşıyaka High School (Izmir, Turkey) in 1995 and Ege University Faculty of Science in 1999. After completing his Master's Degree at Ege University in 2001, he completed his PhD in 2009 at Istanbul University Molecular Biology and Genetics program. He studied at Molecular Hematology laboratory in Istanbul University between 2001 and 2010. Dr.Hancer received his Associate Professor and Professor degrees in 2013 and 2018 respectively. He is currently the head of the Department of Medical Biology, Faculty of Medicine, Istinye University. He is the author of numerous international scientific articles and national / international awards with h-index of 13. His research intrests are cancer genetics and thrombosis genetics. He is a member of the Editorial Board of the Journal of Human Genetics & Embriology and the editor of the Turkish Journal of Hematology. Dr.Hancer is a member of Turkish Hematology Association and Medical Biology and Genetics Association. He speaks English and is married with two children.
Articles
Kruppel-Like Transcription Factor-4 Gene Expression and DNA Methylation Status in Type 2 Diabetes and Diabetic Nephropathy Patients ,2019
Prevalence of human papilloma virus types in Turkish and Albanian women ,2018
A Novel Ganciclovir Resistance Mutation in the UL97 Gene of the HHV-5 in an Adult Hematopoietic Stem Cell Transplant Recipient ,2017
Prognostic significance of carbonic anhydrase IX overexpression in stage III non-small cell lung cancer patients after neoadjuvant treatment ,2018
Novel Pathological Mutation (c.870 GA, p.Trp290stop) in ARSB of Mucopolysaccharidosis Type VI Patients ,2019
Reports
Kruppel Like Factor 4 Gene Expression and DNA Methylation in Patinet with Type 2 Diabetes and Diabetic Nephropathy - COŞKUN ZEYNEP MİNE, ERSÖZ MELİKE, ADAŞ MİNE, HANÇER VEYSEL SABRİ, BOYSAN ŞERİFE NUR, GÖNEN MUSTAFA SAİT, ACAR AYNUR
Two novel calreticulin mutations in a turkish patient with primary myelofibrosis: c.1116delA and c.1120A>C. - güvenç serkan,HANÇER VEYSEL SABRİ,uslu neslihan,ARAT MUTLU,küçükkaya reyhan
Two Pediatric Cases of Essential Thrombocytopenia Characterized By Extremely Rare Mutations. - TOKGÖZ HÜSEYİN,ÇALIŞKAN ÜMRAN,küçükkaya reyhan,demir ahmet,HANÇER VEYSEL SABRİ
The impact of prothrombotic mutations, PSGL-1 VNTR polymorphism, tissue factor and soluble P-selectin on venous thromboembolism in cancer patients with adenocarcinoma. - bozkurt mustafa,OKUTUR SADİ KEREM,aydın kübra,NAMAL ESAT,ÖZTÜRK AKIN,plancı kezban nur,HANÇER VEYSEL SABRİ
Is the Glu298Asp polymorphism of Endothelial Nitric Oxide Synthesis Increase the Risk of Stent Thrombosis? - yalçın ahmet arif,ÖZBAY ÖZYILMAZ SİNEM,aktürk ibrahim faruk,HANÇER VEYSEL SABRİ,uzun fatih,ertürk mehmet,birand ali,ender ömer
